| Trial name or title | Randomized clinical trial to reduce harm from tobacco |
| Methods | Randomized parallel‐assignment efficacy study, single‐blind Setting: Recruitment: |
| Participants | Target 6000 participants Vitality beneficiaries, 18 or older, reported/tested positive for smoking, excluding participants who opt out |
| Interventions | a) Standardized Vitality programme aimed at promoting tobacco cessation. This programme includes existing employee benefits for quitting and the use of text/email messages to encourage tobacco cessation b) as (a), plus free EC c) as (b) plus access to free NRT, bupropion or varenicline d) as (c) plus incentives across 6m for testing negative for tobacco use e) as (c) plus provide money at start and lose money from this fund if they do not test negative across 6m |
| Outcomes | Primary: verified abstinence at 6m Secondary: abstinence at 1, 3 and 12m |
| Starting date | January 2015 |
| Contact information | Scott Halpern, University of Pennsylvania |
| Notes |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.